A Tale of Two Countries: Genotyping To Avoid a Dreaded Drug Side Effect: Topol on Genomics
Links shared publicly online about this topic.
- 281total visits
A Tale of Two Countries: Genotyping To Avoid a Dreaded Drug Side Effect: Topol on Genomics
View full resource at boards.medscape.com
Tags: Seizure Medication, Bipolar Disorder Medication, Neuropathic Pain Medication, Disease and Condition, Drug, FDA, Tegretol
Most Recently Shared on May 19, 2011 at 9:18 pm By:
Topol on PGx: A Tale of Two Countries- Genotyping To Avoid a Dreaded Drug Side Effect. 4' vid via Medscape http://bit.ly/mHk5Zr #pm101 #FDA
A Tale of Two Countries: Genotyping To Avoid a Dreaded Drug Side Effect: Topol on Genomics
boards.medscape.com — “Two articles in the March 24, 2011, issue of the New England Journal of Medicine* highlighted the ability to predict Stevens-Johnson syndrome after administration of carbamazepine. There is one HLA allele for those with European ancestry (HLA-A*3101)” View full resource at boards.medscape.com
Most Recently Shared on May 19, 2011 at 7:32 pm By:
Eric Topol, MD Cardiologist, Physician, Doctor, and Internist
A tale of 2 countries (Taiwan vs US): genotyping to avoid a dreaded side effect http://bit.ly/mrm1Hg
Advertisement
